Nov. 28 at 3:01 PM
$PRPH Bull Quickie DD: Micro-Cap Moonshot @
$0.18 (Nov 28 ’25)
INVESTOR WEBINAR MONDAY DEC 1st
Setup:
$8.6M mkt cap – absurd for a biotech with
$50M+ hidden cash + esophageal cancer test in
$7-14B TAM. Down 80% YTD on noise, catalysts now stacked.
Cash Bomb:
$50M+ COVID receivables (Crown Medical) – first settlement Q3, rest Q4/Q1 ’26. Non-dilutive = 5-6x current mkt cap.
Pipeline: BE-Smart cancer test – patent issued Aug ’25, validation Oct ’25, launch 2026. Nebula Genomics DTC scaling fast + huge AI-ready database.
DAT Rocket: BTC treasury approved Nov 24 (63%+ yes) – buying dips into
$100K+ BTC. Ongoing non-crypto M&A talks at big multiples.
Squeeze: Tiny float + Nasdaq compliance fixed + Dec 1 CEO webinar = short-cover incoming. LPTX 3xed on DAT news; PRPH next.
Upside: 5x near-term (
$0.90 on cash), 20x+ med-term (
$3-4) on M&A/BTC/BE-Smart. Bonus: Pharmaloz OTC (
$80M rev potential).
Dec 1 webinar will light the fuse. 🚀
NFA, verify facts
$VSEE $SOAR $CMBM $INTS
